224 related articles for article (PubMed ID: 22558100)
21. A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability.
Sontrop HM; Moerland PD; van den Ham R; Reinders MJ; Verhaegh WF
BMC Bioinformatics; 2009 Nov; 10():389. PubMed ID: 19941644
[TBL] [Abstract][Full Text] [Related]
22. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
[TBL] [Abstract][Full Text] [Related]
23. Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery.
Grate LR
BMC Bioinformatics; 2005 Apr; 6():97. PubMed ID: 15826317
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of set-level techniques in predictive classification of gene expression samples.
Holec M; Kléma J; Zelezný F; Tolar J
BMC Bioinformatics; 2012 Jun; 13 Suppl 10(Suppl 10):S15. PubMed ID: 22759420
[TBL] [Abstract][Full Text] [Related]
25. Network-based biomarkers enhance classical approaches to prognostic gene expression signatures.
Barter RL; Schramm SJ; Mann GJ; Yang YH
BMC Syst Biol; 2014; 8 Suppl 4(Suppl 4):S5. PubMed ID: 25521200
[TBL] [Abstract][Full Text] [Related]
26. Module-based outcome prediction using breast cancer compendia.
van Vliet MH; Klijn CN; Wessels LF; Reinders MJ
PLoS One; 2007 Oct; 2(10):e1047. PubMed ID: 17940611
[TBL] [Abstract][Full Text] [Related]
27. Feature selection and classification of MAQC-II breast cancer and multiple myeloma microarray gene expression data.
Liu Q; Sung AH; Chen Z; Liu J; Huang X; Deng Y
PLoS One; 2009 Dec; 4(12):e8250. PubMed ID: 20011240
[TBL] [Abstract][Full Text] [Related]
28. Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling.
Castillo D; Gálvez JM; Herrera LJ; Román BS; Rojas F; Rojas I
BMC Bioinformatics; 2017 Nov; 18(1):506. PubMed ID: 29157215
[TBL] [Abstract][Full Text] [Related]
29. Identification of key molecular targets that correlate with breast cancer through bioinformatic methods.
Tang W; Guo X; Niu L; Song D; Han B; Zhang H
J Gene Med; 2020 Mar; 22(3):e3141. PubMed ID: 31697007
[TBL] [Abstract][Full Text] [Related]
30. Class prediction for high-dimensional class-imbalanced data.
Blagus R; Lusa L
BMC Bioinformatics; 2010 Oct; 11():523. PubMed ID: 20961420
[TBL] [Abstract][Full Text] [Related]
31. Accurate molecular classification of cancer using simple rules.
Wang X; Gotoh O
BMC Med Genomics; 2009 Oct; 2():64. PubMed ID: 19874631
[TBL] [Abstract][Full Text] [Related]
32. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes.
Warnat P; Eils R; Brors B
BMC Bioinformatics; 2005 Nov; 6():265. PubMed ID: 16271137
[TBL] [Abstract][Full Text] [Related]
33. Integrating biological knowledge with gene expression profiles for survival prediction of cancer.
Chen X; Wang L
J Comput Biol; 2009 Feb; 16(2):265-78. PubMed ID: 19183004
[TBL] [Abstract][Full Text] [Related]
34. Significant random signatures reveals new biomarker for breast cancer.
Saberi Ansar E; Eslahchii C; Rahimi M; Geranpayeh L; Ebrahimi M; Aghdam R; Kerdivel G
BMC Med Genomics; 2019 Nov; 12(1):160. PubMed ID: 31703592
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
36. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract][Full Text] [Related]
37. Improved prediction of breast cancer outcome by identifying heterogeneous biomarkers.
Choi J; Park S; Yoon Y; Ahn J
Bioinformatics; 2017 Nov; 33(22):3619-3626. PubMed ID: 28961949
[TBL] [Abstract][Full Text] [Related]
38. Feature selection and molecular classification of cancer using genetic programming.
Yu J; Yu J; Almal AA; Dhanasekaran SM; Ghosh D; Worzel WP; Chinnaiyan AM
Neoplasia; 2007 Apr; 9(4):292-303. PubMed ID: 17460773
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.
Reyal F; van Vliet MH; Armstrong NJ; Horlings HM; de Visser KE; Kok M; Teschendorff AE; Mook S; van 't Veer L; Caldas C; Salmon RJ; van de Vijver MJ; Wessels LF
Breast Cancer Res; 2008; 10(6):R93. PubMed ID: 19014521
[TBL] [Abstract][Full Text] [Related]
40. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
Ren H; Hu D; Mao Y; Su X
Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
